RxDoctor Payments Data

Janis Rule

Nurse Practitioner · Huntington, WVNPI 1518274760

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.6% of the total across 246 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by AbbVie at 28.8% of the total. Reporting peaked in 2023 at $1,585 and has fallen 77.4% since, to $359 in 2025. Among nurse practitioner clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,885in general payments, 2019–2025

Across 246 payments — averaging $15.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Alkermes, Inc.$515
  • Otsuka America Pharmaceutical, Inc.$499
  • Johnson & Johnson$467
  • Neurocrine Biosciences, Inc.$439
  • Teva Pharmaceuticals USA, Inc.$341
  • plus $506 from 4 others

What the payments were for

  • Food & beverage$3,868100%
  • Education$170%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,885 in reported general payments places this provider in the 95th percentile of 649 nurse practitioner providers in West Virginia.

See all nurse practitioner providers in West Virginia

Medicare billing

Part B allowed, 2024
$6,066
Medicare patients
32
Services billed
87

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide11$12,150
Breo ElliptaFluticasone/Vilanterol17$7,410
Omeprazole142$1,576
Ventolin HfaAlbuterol Sulfate24$1,504
Albuterol Sulfate HfaAlbuterol Sulfate23$1,012
Fluticasone Propionate55$977
Levothyroxine Sodium67$799
Atorvastatin Calcium72$762
Famotidine33$588
Montelukast Sodium35$400
Lisinopril70$368
Metoprolol Succinate14$337
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl45$281
Amlodipine Besylate61$266
Tamsulosin Hcl13$218

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Huntington

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →